Australia markets closed

InterCure Ltd. (INCR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.8881+0.0781 (+4.31%)
As of 01:25PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close1.8100
Open1.8100
Bid1.8600 x 800
Ask1.8900 x 1800
Day's range1.8000 - 1.9000
52-week range0.9900 - 2.8680
Volume25,169
Avg. volume73,554
Market cap86.046M
Beta (5Y monthly)0.05
PE ratio (TTM)14.52
EPS (TTM)0.1300
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est33.05
  • GlobeNewswire

    InterCure Provides an Update Regarding Nir Oz Facility

    NEW YORK, and HERZLIYA, Israel, Feb. 13, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel and outside of North America, reports today that, further to the Company’s press release issued on October 17, 2023, in which the Company provided an update regarding the status of the security situation in Israel, and its impact on the Company and its employees, the Company is providing an additi

  • GlobeNewswire

    InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain

    NEW YORK, and HERZLIYA, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel and outside of North America, announced today that it has entered into a share purchase agreement (the “Agreement”) with the shareholders of Leon Pharm Ltd. (the “Sellers”, and “Leon Pharm”, respectively) to purchase Leon Pharm, a leading, Israel-based pharmacy chain specializing in dispensing med

  • GlobeNewswire

    InterCure Wins Cannolam Arbitration Proceeding

    NEW YORK and HERZLIYA, Israel , Oct. 31, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel and outside of North America, reports today that, further to the Company’s press release issued on August 31, 2023, in which the Company reported that the Tel Aviv-Jaffa District Court dismissed the lawsuit that filed against the Company by minority shareholders of its subsidiary, Cannolam Ltd. (“